ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00496171
Recruitment Status : Terminated
First Posted : July 4, 2007
Last Update Posted : January 16, 2009
Sponsor:
Information provided by:
Photocure

Brief Summary:
The purpose of the study is to determine the most effective formulation of HAL for release of hexaminolevulinate to the cervical epithelium at different doses.

Condition or disease
Healthy

Study Type : Observational
Time Perspective: Prospective
Official Title: A Phase I Hexaminolevulinate (HAL) Dose-Finding Study Applying Different Formulations to the Cervix in Healthy Volunteers




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy, pre-menopausal female volunteers

Exclusion Criteria:

  • Acute or chronic disease which could influence the study results

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00496171


Locations
Norway
Riks-Radium University Hospital
Oslo, Norway
Sponsors and Collaborators
Photocure
Investigators
Principal Investigator: Claes G Tropé, MD PhD Riks-Radium University Hospital

ClinicalTrials.gov Identifier: NCT00496171     History of Changes
Other Study ID Numbers: PC CE102/07
First Posted: July 4, 2007    Key Record Dates
Last Update Posted: January 16, 2009
Last Verified: January 2009